Mark Baron is a Neurology physician. OpenAlex indexes 71 publications with 2,521 citations (h-index 20); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1250 E Marshall Street
Neurology
Richmond, VA 232980599
Telephone
804-828-9350Registry record last updated 8 Jul 2007.
Clinical trials
- Safety and Efficacy of State-of-the-Art Exoskeleton Technology to Improve Mobility in Parkinson's Disease
Sponsor: Virginia Commonwealth University
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Nervous system
100%Aromatic Amino Acid Decarboxylation Inhibitor71.6%Carbidopa-Levodopa61%Carbidopa-Levodopa Er23%Rytary16%Part D<11 patientsAnti-epileptic Agent10.3%Primidone100%Part D<11 patients+ 2 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
2 NIH research awards on record, funded 2011–2023 per NIH RePORTER. The latest:
- Feasibility and Safety of a Portable Exoskeleton to Improve Mobility in Parkinson’s Disease
Va Veterans Administration Hospital
FY2023I21RX004387 - Advancement and Application of a Novel Basal Ganglia Thalamocortical Circuitry Model in Dystonia Rats
Va Veterans Administration Hospital
FY2022I01BX001147 - Advancement and Application of a Novel Basal Ganglia Thalamocortical Circuitry Model in Dystonia Rats
Va Veterans Administration Hospital
FY2021I01BX001147
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- From molecule to oblivion: dedicated brain circuitry underlies anesthetic loss of consciousness permitting pain-free surgery
Frontiers in Molecular Neuroscience
2023 - Might pain be experienced in the brainstem rather than in the cerebral cortex?
Behavioural Brain Research
2022 - Anesthetic loss of consciousness induced by chemogenetic excitation of mesopontine effector neurons.
Experimental Neurology
2022
Similar KOLs
Other experts from the same institution or the same specialty.
No other directory profiles share this institution yet.
Bruce Miller, MD
University of California, San Francisco (UCSF)
Brett Kissela, MD
Medical College of Wisconsin
Bradley Boeve, MD
Mayo Clinic
Richard Lipton, MD
Albert Einstein College of Medicine
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”